SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:fc4cf98c-a54e-419c-a74b-ea4a9a2c2f5b"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:fc4cf98c-a54e-419c-a74b-ea4a9a2c2f5b" > Use of combined hor...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00007134naa a2200913 4500
001oai:lup.lub.lu.se:fc4cf98c-a54e-419c-a74b-ea4a9a2c2f5b
003SwePub
008190722s2019 | |||||||||||000 ||eng|
009oai:prod.swepub.kib.ki.se:141287995
0247 a https://lup.lub.lu.se/record/fc4cf98c-a54e-419c-a74b-ea4a9a2c2f5b2 URI
0247 a https://doi.org/10.1093/rheumatology/kez0142 DOI
0247 a http://kipublications.ki.se/Default.aspx?queryparsed=id:1412879952 URI
040 a (SwePub)lud (SwePub)ki
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
1001 a Mendel, Arielleu McGill University Health Center4 aut
2451 0a Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen
264 c 2019-02-08
264 1b Oxford University Press (OUP),c 2019
300 a 9 s.
520 a Objectives. To assess the prevalence of combined hormonal contraceptives (CHCs) in reproductive-age women with SLE with and without possible contraindications and to determine factors associated with their use in the presence of possible contraindications. Methods. This observational cohort study included premenopausal women ages 18-45 years enrolled in the SLICC Registry ≤15 months after SLE onset, with annual assessments spanning 2000-2017. World Health Organization Category 3 or 4 contraindications to CHCs (e.g. hypertension, aPL) were assessed at each study visit. High disease activity (SLEDAI score >12 or use of >0.5 mg/kg/day of prednisone) was considered a relative contraindication. Results. A total of 927 SLE women contributed 6315 visits, of which 3811 (60%) occurred in the presence of one or more possible contraindication to CHCs. Women used CHCs during 512 (8%) visits, of which 281 (55%) took place in the setting of one or more possible contraindication. The most frequently observed contraindications were aPL (52%), hypertension (34%) and migraine with aura (22%). Women with one or more contraindication were slightly less likely to be taking CHCs [7% of visits (95% CI 7, 8)] than women with no contraindications [9% (95% CI 8, 10)]. Conclusion. CHC use was low compared with general population estimates (>35%) and more than half of CHC users had at least one possible contraindication. Many yet unmeasured factors, including patient preferences, may have contributed to these observations. Further work should also aim to clarify outcomes associated with this exposure.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Reproduktionsmedicin och gynekologi0 (SwePub)302202 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Obstetrics, Gynaecology and Reproductive Medicine0 (SwePub)302202 hsv//eng
653 a Anti-phospholipid syndrome
653 a Contraception
653 a Epidemiology
653 a Systemic lupus erythematosus
7001 a Bernatsky, Sashau McGill University Health Center4 aut
7001 a Pineau, Christian A.u McGill University Health Center4 aut
7001 a St-Pierre, Yvanu McGill University Health Center4 aut
7001 a Hanly, John G.u Dalhousie University4 aut
7001 a Urowitz, Murray B.u Toronto Western Hospital,University of Toronto4 aut
7001 a Clarke, Ann E.u University of Calgary4 aut
7001 a Romero-Diaz, Juanitau Instituto Nacional de Ciencias Médicas y Nutrición4 aut
7001 a Gordon, Carolineu University of Birmingham,City Hospital, Birmingham4 aut
7001 a Bae, Sang Cheolu Hanyang University4 aut
7001 a Wallace, Daniel J.u Cedars-Sinai Medical Center,University of California, Los Angeles4 aut
7001 a Merrill, Joan T.u Oklahoma Medical Research Foundation4 aut
7001 a Buyon, Jillu New York University4 aut
7001 a Isenberg, David A.u University College London4 aut
7001 a Rahman, Anisuru University College London4 aut
7001 a Ginzler, Ellen M.u SUNY Downstate Health Sciences University4 aut
7001 a Petri, Michelleu Johns Hopkins University School of Medicine4 aut
7001 a Dooley, Mary Anneu University of North Carolina4 aut
7001 a Fortin, Paulu Centre hospitalier universitaire de Québec4 aut
7001 a Gladman, Dafna D.u Toronto Western Hospital,University of Toronto4 aut
7001 a Steinsson, Kristjánu National University Hospital of Iceland4 aut
7001 a Ramsey-Goldman, Rosalindu Northwestern University Feinberg School of Medicine4 aut
7001 a Khamashta, Munther A.u University College London4 aut
7001 a Aranow, Cynthiau Feinstein Institute for Medical Research4 aut
7001 a MacKay, Megganu Feinstein Institute for Medical Research4 aut
7001 a Alarcón, Gracielau University of Alabama4 aut
7001 a Manzi, Susanu Allegheny Health Network4 aut
7001 a Nived, Olau Lund University,Lunds universitet,Reumatologi och molekylär skelettbiologi,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Rheumatology,Section III,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)reum-oni
7001 a Jönsen, Andreasu Lund University,Lunds universitet,Lund SLE Research Group,Forskargrupper vid Lunds universitet,Lund University Research Groups4 aut0 (Swepub:lu)reum-ajo
7001 a Zoma, Asad A.u Hairmyres Hospital4 aut
7001 a Van Vollenhoven, Ronald F.u Karolinska Institutet,Karolinska Institute4 aut
7001 a Ramos-Casals, Manuelu Hospital Clínic of Barcelona4 aut
7001 a Ruiz-Irastorza, Giuillermou University of the Basque Country4 aut
7001 a Lim, Samu Emory University4 aut
7001 a Kalunian, Kenneth C.u University of California, San Diego4 aut
7001 a Inanc, Muratu Istanbul University4 aut
7001 a Kamen, Diane L.u Medical University of South Carolina4 aut
7001 a Peschken, Christine A.u University of Manitoba4 aut
7001 a Jacobsen, Sørenu Copenhagen University Hospital,University of Copenhagen4 aut
7001 a Askanase, Ancau Columbia University4 aut
7001 a Sanchez-Guerrero, Jorgeu University of Toronto,Mount Sinai Hospital of University of Toronto4 aut
7001 a Bruce, Ian N.u University of Manchester,Manchester University NHS Foundation Trust4 aut
7001 a Costedoat-Chalumeau, Nathalieu Cochin Hospital4 aut
7001 a Vinet, Evelyneu McGill University Health Center4 aut
7102 a McGill University Health Centerb Dalhousie University4 org
7730 t Rheumatology (United Kingdom)d : Oxford University Press (OUP)g 58:7, s. 1259-1267q 58:7<1259-1267x 1462-0324x 1462-0332
8564 u http://dx.doi.org/10.1093/rheumatology/kez014y FULLTEXT
8564 u https://europepmc.org/articles/pmc6821299?pdf=render
8564 8u https://lup.lub.lu.se/record/fc4cf98c-a54e-419c-a74b-ea4a9a2c2f5b
8564 8u https://doi.org/10.1093/rheumatology/kez014
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:141287995

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy